News Article
Gender-affirming therapy using medroxyprogesterone acetate has few side affects
10 May 2019

According to research published in the Journal of Clinical Endocrinology and Metabolism, the use of medroxyprogesterone acetate in transgender women significantly reduces testosterone without impacting estradiol levels.

Endocrinology Advisor